The Clorox Company CLX
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 33.31% | -2.01% | 0.12% | -0.77% | -18.90% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 33.31% | -2.01% | 0.12% | -0.77% | -18.90% |
| Cost of Revenue | 36.25% | 7.52% | 2.38% | 0.11% | -12.87% |
| Gross Profit | 29.19% | -12.99% | -2.70% | -1.90% | -26.05% |
| SG&A Expenses | 8.11% | 10.02% | -14.68% | -3.21% | -8.07% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -40.00% | -16.67% | 233.33% | 50.00% | 600.00% |
| Total Operating Expenses | 25.73% | 8.02% | -2.87% | -0.96% | -10.82% |
| Operating Income | 116.81% | -39.81% | 17.84% | 0.43% | -59.39% |
| Income Before Tax | 93.46% | -48.05% | 0.79% | -9.28% | -39.55% |
| Income Tax Expenses | 36.00% | -37.84% | 3.17% | 25.58% | -66.22% |
| Earnings from Continuing Operations | 110.98% | -50.30% | 0.00% | -17.01% | -20.39% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -50.00% | 0.00% | 20.00% | -300.00% | 50.00% |
| Net Income | 112.50% | -50.90% | 0.54% | -18.65% | -19.19% |
| EBIT | 116.81% | -39.81% | 17.84% | 0.43% | -59.39% |
| EBITDA | 89.71% | -30.91% | 15.54% | 1.05% | -49.57% |
| EPS Basic | 114.26% | -50.23% | 2.20% | -17.21% | -18.42% |
| Normalized Basic EPS | 115.05% | -50.66% | 20.54% | -1.01% | -64.50% |
| EPS Diluted | 113.85% | -50.09% | 2.67% | -16.23% | -18.72% |
| Normalized Diluted EPS | 115.03% | -50.55% | 20.81% | -0.56% | -64.37% |
| Average Basic Shares Outstanding | -0.82% | -1.36% | -1.62% | -1.75% | -0.94% |
| Average Diluted Shares Outstanding | -0.81% | -1.56% | -1.84% | -2.20% | -1.33% |
| Dividend Per Share | 0.81% | 0.81% | 0.00% | 1.64% | 1.64% |
| Payout Ratio | -0.53% | 1.04% | -0.01% | 0.23% | 0.24% |